Microvesicle-associated tissue factor and Trousseau's syndrome

95Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Trousseau's syndrome is a prothrombotic state associated with malignancy that is poorly understood pathophysiologically. Methodsand Results: Here we report studies on the blood of a 55-year-old man with giant-cell lung carcinoma who developed a severe form of Trousseau's syndrome. His clinical course was dominated by an extremely hypercoagulable state. Despite receiving potent antithrombotic therapy, he suffered eleven major arterial and venous thrombotic events over a 5 month period. We examined the patient's blood for tissue factor (TF), the major initiator of coagulation, and found its concentration in his plasma to be forty-one-fold higher than the mean concentration derived from testing of 16 normal individuals. Conclusion: Almost all of the TFin the patient's plasma was associated with cell-derived microvesicles, likely shed by the cancer cells. © 2007 International Society on Thrombosis and Haemostasis.

Cite

CITATION STYLE

APA

Del Conde, I., Bharwani, L. D., Dietzen, D. J., Pendurthi, U., Thiagarajan, P., & López, J. A. (2007). Microvesicle-associated tissue factor and Trousseau’s syndrome. Journal of Thrombosis and Haemostasis, 5(1), 70–74. https://doi.org/10.1111/j.1538-7836.2006.02301.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free